An Investment Case to Prevent the Reintroduction of Malaria in Sri Lanka

by Rima Shretta, Ranju Baral, Anton L. V. Avanceña et al.VAm. J. Trop. Med. Hyg., 96(3), 2017, pp. 602–615

14 pp. 1.9 MB
http://www.ajtmh.org/deliver/fulltext/14761645/96/3/602.pdf?
itemId=/content/journals/10.4269/ajtmh.16-
0209&mimeType=pdf&containerItemId=content/journals/14761645

Sri Lanka has made remarkable gains in reducing the burden of malaria, recording no locally transmitted malaria cases since November 2012 and zero deaths since 2007. The country was recently certified as malaria free by World Health Organization in September 2016. Sri Lanka, however, continues to face a risk of resurgence due to persistent receptivity and vulnerability to malaria transmission. Maintaining the gains will require continued financing to the malaria program to maintain the activities aimed at preventing reintroduction. This article presents an investment case for malaria in Sri Lanka by estimating the costs and benefits of sustaining investments to prevent the reintroduction of the disease.

(Visited 3 times, 1 visits today)
This entry was posted in General, Malaria. Bookmark the permalink.